Extracorporeal circulation as a new experimental pathway for myoblast implantation in mdx mice

Cell Transplantation

Volumn 8, Issue 3, 1999, Pages 247-258

  Torrente, Y ^a   D'Angelo, M G ^b   Del Bo, R ^c   DeLiso, A ^b   Casati, R ^a   Benti, R ^a   Corti, S ^b   Comi, G P ^a,b   Gerundini, P ^a   Anichini, A ^d   Scarlato, G ^a,b   Bresolin, N ^a,b  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c SCIENTIFIC INSTITUTE   (Italy)

^d NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Extracorporeal circulation; Gene therapy; Myoblast transplantation

Indexed keywords

DYSTROPHIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CELL VIABILITY; CONTROLLED STUDY; DUCHENNE MUSCULAR DYSTROPHY; EXTRACORPOREAL CIRCULATION; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER; GENETIC TRANSFECTION; IMPLANTATION; MALE; MOUSE; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REPORTER GENE;

ANIMALIA;

EID: 0032788380     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.1177/096368979900800305     Document Type: Article

References (32)

1. Alameddine, H. S.; Hantai, D.; Dehaupas, M.; Fardeau, M. Role of persisting basement membrane in the reorganization of myofibres originating from myogenic cell grafts in the rat. Neuromusc. Disord. 1:143-152; 1991.
2. Asselin, I.; Tremblay, M.; Vilquin, J. T.; Guerette, B.; Roy, R.; Tremblay, J. P. Quantification of normal dystrophin mRNA following myoblasts transplantation in mdx mice. Muscle Nerve 18:980-986; 1995.
3. Blau, H. M. Muscling in on gene therapy. Nature 364: 673-675; 1993.
4. Blochlinger, K.; Diggelmann, H. Hygromycin B phosphotransferase as a selectable marker for DNA transfer experiments with higher eucaryotic cells. Mol. Cell. Biol. 4: 2929-2931; 1984.
5. Bresolin, N.; Ausenda, C. D.; Casati, R.; Torrente, Y.; DeLiso, A.; D'Angelo, M. G.; Benti, R.; Moggio, M.; Baldessari, S.; Comi, G. P.; Colombo, F.; Gerundini, P.; Scarlato, G. Intra-aortic injection of myoblasts in mdx mice: Genetic and Tc-99m cell labelling and biodistribution. Muscle Nerve 20:757-759; 1997.
6. Davis, H. L.; Jasmin, B. J. Direct gene transfer into mouse diaphragm. FEBS 2:146-150; 1993.
7. Ecob-Prince, M. S.; Jenkison, M.; Butler-Browne, G. S.; Whalen, R. G. Neonatal and adult myosin heavy chain isoforms in a nerve-muscle culture system. J. Cell Biol. 103:995-1005; 1986.
8. Fassati, A.; Wells, D. J.; Walsh, F. S.; Dickson, G. Efficiency of in vivo gene transfer using murine retroviral vectors is strain-dependent in mice. Hum. Gene Ther. 6: 1177-1183; 1995.
9. Ferrari, G.; Cusella-De Angelis, G.; Coletta, M.; Paolucci, E.; Stornaiuolo, A.; Cossu, G.; Mavilio, F. Muscle regeneration by bone marrow-derived myogenic progenitors. Science 279:1528-1530; 1998.
10. Halls-Craggs, E. C. B. Rapid degeneration and regeneration of a whole skeletal muscle following treatment with bupivacaine (Marcain). Exp. Neurol. 43:349-358; 1974.
11. Hoffman, E. P.; Morgan, J. E.; Watkins, S. C.; Partridge, T. A. Somatic reversion/suppression of the mouse mdx phenotype in vivo. J. Neurol. Sci. 99:9-25; 1990.
12. Ibraghimov-Beskrovnaya, O.; Ervasti, J. M.; Leveille, C. J.; Slaughter, C. A.; Sernett, S. W.; Campbell, K. P. Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix. Nature 355: 696-702; 1992.
13. Juttermann, R.; Li, E.; Jaenisch, R. Toxicity of 5 aza 2′ deoxycitidine to mammalian cells is mediated primarly by covalent trapping of DNA methyltransferase rather than DNA demethylation. Proc. Natl. Acad. Sci. USA 91: 11797-11801; 1994.
14. Kinoshita, I.; Asselin, I.; Vilquin, J. T.; Chamberlain, J.; Tremblay, J. P. Transplantation of myoblasts from a transgenic mouse overexpressing dystrophin produced only a relatively small increase of dystrophin-positive membrane. Muscle Nerve 21:91-103; 1998.
15. Knothe, C. H.; Boldt, J.; Zickmann, B.; Konstantinov, S.; Dick, P.; Dapper, F.; Hempelmann, G. Influence of different flow modi during extracorporeal circulation on endothelial-derived vasoactive substances. Perfusion 4:229-236; 1995.
16. Kronague, J. F.; Chiu, M. L.; Cone, J. S. Comparison of neutral and cationic myocardial perfusion agents; characteristics of accumulation in cultured cells. Nucl. Med. Biol. 19:141-148; 1992.
17. MacGregor, G. R.; Caskey, C. T. Construction of plasmids that express E. coli beta-galactosidase in mammalian cells. Nucleic Acids Res. 17:2365; 1989.
18. Mendell, J. R.; Kissel, J. T.; Amato, A. A.; King, W.; Signore, L.; Prior, T. W.; Sahenk, Z.; Benson, S.; McAndrew, P. E.; Rice, R. Myoblast transfer in the treatment of Duchenne's muscular dystrophy. N. Engl. J. Med. 28: 832-838; 1995.
19. Menger, F. M.; Williams, D. Y. Synthesis and properties of a surfactant-cyclodextrin conjugate. Tetrahedron Lett. 27(23):2579-2582; 1986.
20. Neumayer, A. M.; Di Gregorio, D. M.; Brown, R. H. Arterial delivery of myoblasts to skeletal muscle. Neurology 42:2258-2262; 1992.
21. Partridge, T. A.; Morgan, J. E.; Coulton, G. R.; Hoffmann, E. P.; Kunkel, L. M. Conversion of mdx myofibers from dystrophin-negative to positive by injection of normal myoblasts. Nature 337:176-179; 1989.
22. Pasqualini, R.; Duatti, A.; Bellande, E.; Comazzi, V.; Brucato, V.; Hoffschir, D.; Fagret, D.; Comet, M. Bis (dithiocarbamato) nitrido technetium-99m radiopharmaceuticals: A class of neutral myocardial imaging agent. J. Nucl. Med. 35:334-341; 1994.
23. Pasqualini, R.; Duatti, A. Synthesis and characterization of the neutral myocardial agent (99mTcN(noet)2). J. Chem. Soc. Chem. Commun. 92:1354-1355; 1992.
24. Patapoutian, A.; Miner, J. H.; Lyons, G. E.; Wold, B. Isolated sequences from the linked Myf-5 and MRF-4 genes drive distinct patterns of muscle-specific expression in transgenic mice. Development 118:61-69; 1993.
25. Prelle, A.; Moggio, M.; Comi, G. P.; Gallanti, A.; Checcarelli, N.; Bresolin, N.; Ciscato, P.; Fortunato, F.; Scarlato, G. Congenital myopathy associated with abnormal accumulation of desmin and dystrophin. Neuromusc. Disord. 2:169-175; 1992.
26. Richler, C.; Yaffe, D. The in vitro cultivation and differentiation capacities of myogenic cell lines. Dev. Biol. 23: 1-22; 1970.
27. Sambrook, J.; Fritsch, E. F.; Maniatis, T. Molecular cloning: A laboratory manual. Cold Spring Harbor: Cold Spring Harbor Laboratory Press; 1989.
28. Shrager, J. B.; Naji, A.; Kelly, A. M.; Stedman, H. H. A PCR-based assay for the wild-type dystrophin gene transferred into the mdx mouse. Muscle Nerve 15:1133-1137; 1992.
29. Sicinski, P.; Geng, Y.; Ryder-Cook, A. S.; Barnard, E. A.; Darlison, M. G.; Barnard, P. J. The molecular basis of muscular dystrophy in the mdx mouse: A point mutation. Science 244:1578-1580; 1989.
30. Sueda, T.; Nagata, H.; Mitsui, N.; Sueshiro, M.; Orihashi, K.; Shikata, H.; Matsuura, Y. Evaluation of serum granulocyte colony stimulating factor and granulocyte counts in patients with extracorporeal circulation. Nippon Kyobu Geka Gakkai Zasshi 43:946-950; 1995.
31. Tremblay, J. P.; Malouin, F.; Roy, R.; Huard, J.; Bouchard, J. P.; Satoh, A.; Richard, C. L. Results of a triple blind clinical study of myoblast transplantations without immunosuppresive treatment in young boys with Duchenne muscular dystrophy. Cell Transplant. 2:99-112; 1993.
32. Walgenbach, K. J.; Gratas, C.; Shestak, K. C.; Becker, D. Ischaemia-induced expression of bFGF in normal skeletal muscle: A potential paracrine mechanism for mediating angiogenesis in ischaemic skeletal muscle. Nat. Med. 5: 453-459; 1995.